Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
View Digital Edition
HOPA’s 10-Year Anniversary Marks Rapid Developments in Hematology/ Oncology Pharmacy
Patrick J. Medina, PharmD, BCOP
Read More
Original Article
A Retrospective Chart Review on the Toxicity of Pegylated Asparaginase in Adult Patients with Acute Lymphoblastic Leukemia
Cindy Ippoliti, PharmD
,
Monank Patel, PharmD
Read More
Drug Profiles/Updates
Concise Review of Obinutuzumab in the Treatment of Patients with Chronic Lymphocytic Leukemia
Peter Tang, PharmD Candidate
,
Tristan Lindfelt, PharmD, BCPS, BCACP, BCOP
,
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
FDA Oncology Update
Recent Cancer Drugs Approved by the FDA
Read More
From the Literature
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Read More
Results 1 - 5 of 5